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Abstract
Background: Patients with allergies can be protected from potentially life threatening harm by recording their
allergen and reaction correctly. Electronic prescribing is being widely implemented with a view to improving
patient safety; decision support functions can alert prescribers to the risk of prescribing an allergen. However the
allergen must be correctly recorded to utilize this functionality. This study aimed to explore whether the
introduction of an inpatient electronic prescribing system, in place of paper-based prescribing, has affected the
accuracy of transfer of allergen data between hospital documentation systems.
Methods: Retrospective case note review of a random sample of 100 patients admitted to two oncology wards in
a UK hospital before implementation of electronic prescribing, and 100 admitted afterwards. We compared
accuracy of allergy information transcribed from admission documentation to the inpatient prescribing system and
then to the separate electronic discharge summary for paper-based versus electronic inpatient prescribing. We
analyzed data separately for patients with no known drug allergy and those with a recorded allergen.
Results: There was no difference between prescribing systems in the transfer of ‘no known drug allergy’ status
from the admission documentation to the inpatient prescribing record. However transfer of ‘no known drug allergy’
status was better on electronic discharge summaries prepared from the separate electronic inpatient system
(transferred correctly for 58 of 72 discharges, 81 %) when compared with paper inpatient prescriptions (26 of 68
patient discharges, 38 %) p < 0.001.
For patients with an allergy the correct transfer of allergens from admission documentation to the inpatient
prescribing record was lower for the electronic prescribing system (10 of 28 patient admissions, 36 %) when
compared with paper prescribing (21 of 32 patient admissions, 66 %) p = 0.02. However correct transfer of allergen
information from the inpatient prescription to electronic discharge summary was better with electronic prescribing,
being transferred correctly in 68 % (19 of 28) patients compared to 38 % (12of 32) with paper prescriptions p = 0.02.
Conclusion: Implementing inpatient electronic prescribing does not guarantee a safer system for patients with
allergies. The usability of the user interface for allergen recording may be an important selection criterion when
purchasing an inpatient electronic prescribing system.
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Background
Giving someone a medicine to which they are known to
have an allergy, sensitivity or intolerance is a potentially
avoidable source of harm. Analysis of patient safety inci-
dents reported to the National Reporting and Learning
System in England and Wales between 2005 and 2013
identified 18,079 incidents involving drug allergy. These
comprised 6 deaths, 19 'severe harms', 4,980 'other harms'
and 13,071 'near misses'. The majority involved a drug
that was prescribed, dispensed and/or administered to a
patient with a previously known allergy to that drug or
drug class and can thus be considered preventable [1].
The document ‘Building a safer NHS for patients’
recommended documenting the severity of any previ-
ous adverse drug reaction in order to differentiate be-
tween allergies and intolerances [2]. For example, if
an intolerance to an antibiotic is recorded as an al-
lergy, a patient may be prescribed antibiotics that are
less effective or more toxic, have a broader spectrum,
and/or are more expensive than the drug of choice
for their condition [3].
Electronic prescribing (EP) can include drug-allergy
decision support functionality; in the US, this has
been shown to reduce prescribing of drugs to which
a patient has a documented allergy [4]. Internation-
ally, drug-allergy decision support is recommended
for inclusion in newly implemented EP systems to im-
prove patient safety [5, 6]. In order to trigger an alert
at the prescribing stage, the prescribing system needs
to have access to the patient’s documented allergies
in a coded way so they can be matched to the pre-
scribing drug database [7]. This can be difficult to
achieve due to the need to avoid classes of drugs ra-
ther than just a named allergen for many cases; for
example all anti-bacterials with a beta lactam struc-
ture may need to be avoided in a patient who has
had an allergic reaction to flucloxacillin. In order to
be able to match the allergen with a prescribed medi-
cine, EP systems with drug-allergy decision support
typically provide an interface to select allergens from
drug libraries, often in the form of drop-down lists.
It is not known how the introduction of inpatient EP
affects the documentation of allergies during a hospital
admission nor the transfer of this information between
healthcare organizations after discharge.
Our aim was to assess whether the introduction of
an inpatient EP system, in place of paper-based pre-
scribing, affected the accuracy of transfer of allergen
recording and thus patient safety. Our objectives were
to compare the EP and paper systems in terms of ac-
curacy of transfer of information on drug allergies be-
tween the admitting doctor’s documentation, the




This study was conducted in an English teaching hos-
pital with 1,044 inpatient beds. A commercially available
EP system (JAC Computer Services, Basildon, Essex)
with drug allergy clinical decision support functionality
had been implemented in 2012 to replace an inpatient
paper prescribing system. The user interface for adding
allergens was reported locally to be difficult to use. The
system required allergy status to be completed before
any medication orders could be added. The allergy status
could be selected as ‘No known drug allergy’ (NKDA),
or ‘Allergy status undetermined’, or a specific drug se-
lected from a drop-down list of drugs comprising both
individual drugs and drug classes. If a drug or drug class
was chosen, details of the reaction experienced were re-
quired in a mandatory field, selected from a drop-down
menu of five reactions plus an ‘Other- see note’ option.
The EP system required the allergy status of an indi-
vidual to be reconfirmed by the first prescriber when
the patient was readmitted. There was no other valid-
ation system for this data. The paper prescription
chart used previously had a prominent allergy docu-
mentation box on the front cover, prompting the user
to record allergies and reactions or “NKDA” rather
than leave the box blank.
The EP system was linked to a pre-existing separate
electronic discharge summary system in which comple-
tion of the allergy field was not mandatory. The allergy
information was transferred only when the medicines se-
lected for discharge on the inpatient prescribing system
were ‘pulled through’ to the discharge summary; this
could also be by-passed by the user by entering medi-
cines manually on the discharge summary.
Two oncology wards, with a total of 50 inpatients
beds, were selected for this study. The medical teams
comprised doctors with at least one year’s post graduate
experience. The implementation of EP on these wards
did not coincide with any changes in the medical team.
All prescribing users of the EP system completed an on-
line training package, with a mandatory test that in-
cluded recording of allergies, before their username and
password were assigned.
Study design
A retrospective case note review study, with a before-
and-after design, was carried out to compare allergy
documentation in a random sample of 100 patients ad-
mitted to the two oncology wards in the paper inpatient
prescribing period (November 2011 to August 2012) and
100 in the EP period (November 2012 to August 2013).
This study was considered an audit and was approved
locally as such.
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Sample size
The sample size calculation was based on having power
to detect a difference between the paper and EP systems
in accuracy of allergen transcription from the inpatient
prescribing system to the discharge summary for pa-
tients with one or more allergies. A pilot study showed
the prevalence of recorded drug allergy on the oncology
wards to be 16 of 49 inpatients across both wards
(33 %), as identified using the EP system. We assumed
that transcription of drug allergen information from the
paper prescription to the discharge summary would be
the weakest part of the system, with allergen accurately
transcribed in 40 % of cases; and that the correct tran-
scription of drug allergy from the EP system to the elec-
tronic discharge summary system would be 85 %. Alpha
was set at 5 % and Beta at 20 %. The required sample
size for each group was 28 patients. In order to be cer-
tain of achieving this number of patients with an allergy
for each type of prescribing, 100 patients were sought
for each group. Time series data collection was selected
to limit possible bias due to clinician variation. Data
were therefore collected by month; we studied ten pa-
tients each month for ten months of paper prescribing
and then again for ten months of EP.
Data collection
Allergy information was collected from admission docu-
mentation, the paper or electronic inpatient prescribing
system, and the discharge summary. Patients admitted
to the two oncology wards were selected at each of ten
separate time points, a randomly selected day each
month, until two weeks before implementation of the EP
system. The ten time points for the EP group started six
weeks after EP implementation and were selected to be
the corresponding week-days to the randomly selected
dates of the paper based group.
At each time point, we randomly selected 20 patients
and then included the first ten whose medical records
were available for the selected admission. The following
documentation was required for each patient: admission
documentation, the inpatient prescribing chart (paper or
electronic), and a discharge summary (unless they died
during the admission). Patients could be included more
than once if they had repeat admissions during the study
period. Selected patients were excluded if their medical
records were not available at the time of the data collec-
tion or if any of the required documentation was absent.
The data collected for each patient compared the al-
lergy record on the admitting documentation with the
allergy record on the inpatient prescribing system at the
time of admission; for each patient these records were
classified as the same or different. The allergy informa-
tion on the discharge summary was then compared with
the allergy information on the inpatient prescribing
system at the time of discharge and again classified as
the same or different. Each patient was classified as hav-
ing NKDA if no allergies were recorded on any source
documentation or as having an allergy if an allergy was
reported on any of the source documentation.
The gender and grade of the admitting clinician were
recorded, when available to the data collector, in order
to assess comparability between EP and paper based pre-
scribing groups.
Analysis
The patients were classified as having either NKDA or
allergies in order to carry out statistical comparison sep-
arately for transfer of NKDA and allergen information
between inpatient systems.
Statistical analysis was undertaken using IBM SPSS
statistics software version 21.0. An independent samples
t-test was used to make comparisons between normally
distributed variables (age of patient, duration of hospital
stay). Chi-square tests were used to compare categorical
variables (gender of patient and admitting clinician,
qualification of admitting clinician, allergy status and
whether or not the patient died during the admission).
Odds ratios were calculated where appropriate.
The hypotheses tested were: (1) there was no differ-
ence between the EP and paper systems in the accuracy
of transcription of allergen data from the admission
documentation to the inpatient prescribing system and
(2) there was no difference between the EP and paper
systems in the accuracy of transcription of allergen data
from the inpatient prescribing system to the discharge
summary.
Results
Characteristics of the study population
There were 100 patients in each of the paper prescribing
and EP groups. Characteristics of each group were very
similar with no statistically significant differences identi-
fied (Table 1). Sixty eight percent of patients in the paper
prescribing group had NKDA; the corresponding figure
was 72 % in the EP group (p = 0.716).
Accuracy of data transfer for patients with NKDA
The NKDA information on the admission documenta-
tion was the same as that on the inpatient prescribing
system for 50 of 68 (74 %) patients in the paper prescrib-
ing group and 57 of 72 (79 %) in the EP group (p = 0.43).
The omission of allergy status from both the admission
documentation and the electronic prescribing record oc-
curred in two patients with paper prescribing. For one
patient in the EP group no allergy status was recorded
on the admission documentation and ‘Allergy status un-
determined’ was selected on the EP system.
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The discrepancies in allergy status records for the six-
teen paper prescribing patients and fourteen EP patients
were due to no allergy record being made on the admis-
sion documentation but ‘NKDA’ being recorded on the
inpatient prescribing record (twelve in each of the paper
prescribing and EP groups) and ‘NKDA’ being recorded
on the admission documentation but allergy status not
being specified on the inpatient prescribing record (two
in the paper prescribing group and one in the EP group).
One patient in the EP group had ‘NKDA’ on the admis-
sion notes and ‘Other Reaction: Other adverse reaction
see note’ in the EP system. This referred to a note left
on a previous admission referring to gastro-oesophageal
reflux with red wine and rosemary; this information was
not immediately available to prescribers. The final dis-
crepancy in allergy status records were two patients in
the paper prescribing group who had non-drug allergies
recorded on their admission notes and inpatient pre-
scriptions, relating to cats and mushrooms, but no refer-
ence was made to allergies to medicines.
The transfer of NKDA information from the in-
patient prescribing system to the discharge summary
was more reliable in the EP group; we identified cor-
rect transfer for 58 of 72 of EP patients (81 %) com-
pared to 26 of 68 patients (38 %) in the paper
prescribing group (p = <0.001; odds ratio 6.69).
Table 1 Summary of characteristics of subjects in each group (N = 200 patients in total)
Characteristic Paper prescribing n = 100
patients (%)
Electronic Prescribing n = 100
patients (%)
p Value
Age of patient (years) 0.085 (t-test)
Mean ± Standard Deviation (SD) 59.0 ± 15.11 62.54 ± 13.75
Median 61.0 64.5
Range 26 to 89 24 to 85
Duration of Hospital Stay (days) 0.488 (t-test)
Mean ± SD 6.9 ± 6.65 7.7 ± 9.39
Median 5.0 5.0
Range 0 to 42 0 to 62
Gender of patient 1.00 (Chi-squared)
Male 64 (64) 64 (64)
Female 36 (36) 36 (36)
Allergy status 0.716 (Chi-squared)
Reported allergy 32 (32) 28 (28)
No known drug allergy 68 (68) 72 (72)
Subject died during admission 0.552 (Chi-squared)
Yes 5 (5) 7 (7)
No 95 (95) 93 (93)
Errors in transcription of allergy from admission
documentation to inpatient system
(Chi-squared)
Incomplete entries (N = 200 patients) 4 of 100 (4 %) 9 of 100 (9 %) 0.152
Illegible (handwritten only) or incorrect entries
(wrong drug selected) (N = 200 patients)
7 of 100 (7 %) 5 of 100 (5 %) 0.616
Profession/Grade of admitting clinician 0.676 (Chi-squared)
Nurse 1 (1) 1(1)
Junior doctor, note all qualified more than one year. 79 (79) 74 (74)
Registrar 24 (24) 20 (20)
Not recorded in medical notes 0 (0) 1 (1)
Gender of admitting clinician 0.517 (Chi-squared)
Male 51 (51) 43 (43)
Female 46 (46) 53 (53)
Not known to data collector 3 (3) 4 (4)
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Accuracy of data transfer for patients with a reported
allergy
The allergen information on the admission documen-
tation matched that on the inpatient prescribing sys-
tem for 21 of 32 (66 %) patients in the paper
prescribing group but only 10 of 28 (36 %) of the EP
group (p = 0.02). We identified five patients in each of
the EP and paper prescribing groups who had a docu-
mented allergy on their prescribing records but noth-
ing recorded in the admission notes. The remaining
mismatches were where patients had allergies re-
corded on their admission documentation that were
not transferred to their inpatient prescription. Pre-
scribers recorded allergens on paper inpatient pre-
scriptions more completely; this may be due to the
users finding it difficult to find the relevant allergen
from the drop down menu of the EP system.
The transfer of allergen information from the inpatient
prescription chart to the discharge summary was more
reliable in the EP group; we identified correct transfer in
19 of 28 of the EP cases (68 %) compared with correct
transfer of allergen for 12 of 32 cases (38 %) in the paper
prescribing group (p = 0.02; odds ratio 3.52).
Discussion
Key findings
The recording of allergy status on the inpatient prescrib-
ing record for patients with NKDA showed little im-
provement with EP when compared with paper
prescriptions.
The standard of allergy recording for the paper pre-
scriptions was higher than expected; Cantrill and
Cottrell reported allergy documentation was present for
31 % (n = 510) of inpatient paper prescriptions in a one-
day audit in a British hospital in 1997 [8]. The higher
standard for paper prescriptions may be because record-
ing allergy status of patients has been high on the safety
agenda for NHS patients in England and Wales for over
a decade [2], therefore the standard of practice was
already relatively high for a paper system.
The transfer of allergy information to other healthcare
providers is also important in maintaining patient safety
[9, 10]. The link between the EP system and the dis-
charge summary led to an improvement in NKDA docu-
mentation on discharge summaries: from 38 % with
paper prescriptions to 81 % in EP patients, p < 0.001.
This would be expected to rise to 100 % in organizations
where the inpatient EP system is also used to provide
the discharge summary without requiring any transcrip-
tion or data transfer.
Patients with a reported allergy were studied separately
and transfer of this information from the admission
documentation to the inpatient prescribing system was
significantly worse in EP, being correctly transferred in
36 % of patients, compared with 66 % of patients with
paper inpatient prescribing. The data transfer relating to
allergen and severity of reaction seemed to be worse in
the EP group due to the limited number of reactions to
allergens on the locally produced drop down list. As a
result of this study the list of allergic reactions is to be
increased locally. The transfer to the discharge summary
of drug names to which a patient had an allergy was im-
proved with EP when compared with paper prescribing.
Comparison with previous literature
Our work supports previous reports describing the chal-
lenges associated with allergen input into EP systems [11].
Implications for future research
We would recommend this work be replicated in other
organizations and other EP systems, perhaps using a
prospective method of patient selection focusing on
those known to have allergies. The findings should be
made available to suppliers of EP systems to aid in the
development of safer systems. Purchasers of EP systems
should assess the usability not just the specification of
the software when comparing products.
This study has shown that the recording of NKDA
was done relatively well and therefore the next study of
the local system will be done prospectively identifying
patients with a drug allergy at the time of admission and
following them through when allergy is transcribed to
the inpatient and discharge documentation systems. The
study will be done after software upgrade and extension
of the allergic reaction drop-down list.
Strengths and limitations
Strengths of this study include the time series method of
data collection, minimizing possible influences on the
clinician in relation to allergy documentation including
their training, experience and familiarity with the EP
system.
Limitations include the retrospective methodology
which meant authenticity of documented allergies could
not be confirmed with the patients themselves. This study
was carried out on two wards in one teaching hospital be-
fore and shortly after implementation of a commercially
available EP system. Therefore the generalizability of our
findings may be limited. A further study is required
to investigate the causes of inadequate allergen re-
cording on the EP system and how this can be
addressed, which may include changing the user
interface to facilitate adding specific allergens and
reactions to the patient’s electronic record.
Conclusion
Implementing inpatient electronic prescribing does not
guarantee a safer system for patients with allergies. The
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usability of the interface for allergen recording may be
an important selection criterion in relation to patient
safety when selecting an inpatient electronic prescribing
system.
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